Pharmacoresistant epilepsy - epidemiology and current studies

Neurologia i neurochirurgia polska
Krystyna Pierzchala

Abstract

In the last years interest in epileptology has focused on determining the cause and pathomechanism of farmacoresistance in epilepsy. According to epidemiology, the problem of pharmacoresistance concerns about 30% of patients suffering from epilepsy, mainly temporal epilepsy coexisting with hippocampal sclerosis. Drug-resistant epilepsy is frequently based on static or dynamic organic brain damage. Furthermore, those morphological changes and related clinical/psychological dysfuctions lead to intellectual and social consequences as well as to an increase of the mortality rate. Pharmacoresistant epilepsy afflicts various patients with the same form of epilepsy and concerns many antiepileptic drugs with different mechanisms of action. Thus, the genetic conditioning of this state was considered. So far, the multidirectional investigations have proved the importance of interleukin IL-1Beta gene polymorphism, prodynorphin, GABA receptors and the APOEZeta4 allele in pharmaco-resistant epilepsy. Moreover, further factors such as transport protein gene polymorphism (ACB(1), RLIP76/RALBP(1)), genetically modifying receptor changes within the activating/inhibiting system (SCN1A - sodium channels, KV(7) - potassium channels) and drug metab...Continue Reading

References

Jun 1, 1974·Epilepsia·J J Zieliński
Sep 1, 1996·Seizure : the Journal of the British Epilepsy Association·L Nashef, J W Sander
Apr 21, 1999·Epilepsy Research·G Regesta, P Tanganelli
Feb 5, 2000·The New England Journal of Medicine·P Kwan, M J Brodie
Mar 1, 2003·Epilepsy & Behavior : E&B·Graeme J. SillsMartin J. Brodie
Apr 11, 2003·The New England Journal of Medicine·Asra SiddiquiSanjay M Sisodiya
Feb 27, 2004·Pediatric Neurology·Alberto LazarowskiAna Lía Taratuto
Mar 5, 2004·CNS Spectrums·Michael R Sperling
Jul 28, 2004·Trends in Pharmacological Sciences·Martin F Fromm
Apr 5, 2005·Proceedings of the National Academy of Sciences of the United States of America·Sarah K TateDavid B Goldstein
Jun 11, 2005·Epilepsia·Annick SalzmannAlain Malafosse
Sep 29, 2005·BMC Neuroscience·Sanjay AwasthiDamir Janigro
Jan 18, 2006·The Pharmacogenomics Journal·C LonjouUNKNOWN RegiSCAR Group
Feb 28, 2006·Epilepsia·Anne T Berg, Molly M Kelly
Jan 20, 2009·Pharmacogenetics and Genomics·Johanna SistonenAntti Sajantila

❮ Previous
Next ❯

Citations

Oct 17, 2012·Journal of Child Neurology·Sotirios VarlamisAthanasios E Evangeliou
May 3, 2015·Pharmacological Reports : PR·Iwona RadzikStanisław J Czuczwar
Jun 27, 2020·Molecular Genetics & Genomic Medicine·Fenja MarkusMarta Owczarek-Lipska

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.